Immunotherapy for extensive stage small cell lung cancer.

Abstract:

:Small cell lung cancer (SCLC) is an aggressive malignancy. Until recently the standard of care for newly diagnosed patients with extensive-stage disease was chemotherapy consisting of etoposide plus a platinum (EP). The median overall survival (OS) was only about 10 months with this systemic therapy. Immune checkpoint inhibitors were first evaluated as second or subsequent line treatments in extensive stage disease and later in combination with EP in the first-line setting. Recently two randomized phase III trials have demonstrated statistically improved OS with addition of a programmed death ligand-1 (PD-L1) inhibitor to EP. As a result, the standard of care for newly diagnosed patients with extensive-stage SCLC has changed for the first time in decades. However, many patients do not derive benefit from the addition of a PD-L1 inhibitor to EP. In this review we discuss first-line trials of chemoimmunotherapy in extensive stage SCLC and summarize data on second and subsequent line treatment with immune checkpoint inhibitors in immunotherapy-naïve patients. Additionally, we discuss potential biomarkers that could be utilized to select for which patients derive benefit from addition of a PD-L1 inhibitor to EP and propose ways to improve on first-line chemoimmunotherapy.

journal_name

J Thorac Dis

authors

Pacheco JM

doi

10.21037/jtd.2020.01.37

subject

Has Abstract

pub_date

2020-10-01 00:00:00

pages

6212-6224

issue

10

eissn

2072-1439

issn

2077-6624

pii

jtd-12-10-6212

journal_volume

12

pub_type

杂志文章,评审
  • Modified exposure method for gastric mobilization in robot-assisted esophagectomy.

    abstract:Background:We describe a modified method to facilitate gastric mobilization in robotic esophagectomy. Furthermore, we performed a prospective comparative analysis of surgical outcomes between the conventional method and described technique. Methods:From April 1st, 2016 to December 31st, 2016, 59 consecutive patients w...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章

    doi:10.21037/jtd.2017.11.48

    authors: Zheng Y,Zhao XW,Zhang HL,Wang ZH,Wang Y

    更新日期:2017-12-01 00:00:00

  • A rare case of pleomorphic adenoma with difficult diagnosis using biopsy.

    abstract::An 85-year-old woman was found to have a nodule in the left S6 of the lung on computed tomography (CT); the pathological diagnosis from the CT-guided biopsy was adenoid cystic carcinoma. We accordingly performed left lower lobectomy. Pathologically, the biphasic cell population showed admixtures in varying proportions...

    journal_title:Journal of thoracic disease

    pub_type:

    doi:10.21037/jtd.2018.07.82

    authors: Nakamura A,Takuwa T,Kondo N,Watanabe T,Hirota S,Hasegawa S

    更新日期:2018-08-01 00:00:00

  • Hybrid theatre and alternative localization techniques in conventional and single-port video-assisted thoracoscopic surgery.

    abstract::Management of pulmonary nodules in terms of diagnosis and intraoperative localization can be challenging, especially in the minimal invasive video-assisted thoracoscopic surgery (VATS) approach, and may be even more difficult with single port VATS with limited access. The ability to localize small lesions intraoperati...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章,评审

    doi:10.3978/j.issn.2072-1439.2016.02.27

    authors: Zhao ZR,Lau RW,Ng CS

    更新日期:2016-03-01 00:00:00

  • Does an imbalance in circulating vascular endothelial growth factors (VEGFs) cause atrial fibrillation in patients with valvular heart disease?

    abstract:Background:The pathogenesis of atrial fibrillation (AF) remains unclear. Vascular endothelial growth factors (VEGFs) can stimulate fibrosis within the atrium and ventricle. We hypothesized that there is a relationship between the serum VEGFs/soluble vascular endothelial growth factor receptor (sVEGFRs) levels and AF in...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章

    doi:10.21037/jtd.2019.11.32

    authors: Wang K,Liu Y,Huang S,Li H,Hou J,Huang J,Chen J,Feng K,Liang M,Chen G,Wu Z

    更新日期:2019-12-01 00:00:00

  • Infrequent ERBB2 mutations in Chinese patients with non-small cell lung cancer.

    abstract::ERBB2 mutations have been reported to occur in a subset of patients with lung adenocarcinomas or lung squamous cell carcinomas for some ethnicities, but it is unclear for Chinese patients with lung squamous cell carcinomas up to now. We retrospectively evaluated the status of ERBB2 mutations in a large cross-sectional...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章

    doi:10.3978/j.issn.2072-1439.2014.03.20

    authors: Feng S,Ling H,Guo H,Tong L,Hu G,Liao L,Lv X,Tan H,Wu Y

    更新日期:2014-05-01 00:00:00

  • Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors.

    abstract::In the last few years, the treatment of patients with non-small cell lung cancer (NSCLC) has impressively benefitted from immunotherapy, in particular from the inhibition of immune checkpoints such as programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1). However, despite the significant survival b...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章,评审

    doi:10.21037/jtd.2018.11.102

    authors: Berland L,Heeke S,Humbert O,Macocco A,Long-Mira E,Lassalle S,Lespinet-Fabre V,Lalvée S,Bordone O,Cohen C,Leroy S,Hofman V,Hofman P,Ilié M

    更新日期:2019-01-01 00:00:00

  • What can individuals do to reduce personal health risks from air pollution?

    abstract::In many areas of the world, concentrations of ambient air pollutants exceed levels associated with increased risk of acute and chronic health problems. While effective policies to reduce emissions at their sources are clearly preferable, some evidence supports the effectiveness of individual actions to reduce exposure...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章,评审

    doi:10.3978/j.issn.2072-1439.2014.12.21

    authors: Laumbach R,Meng Q,Kipen H

    更新日期:2015-01-01 00:00:00

  • Robot-assisted thymectomy via subxiphoid approach: technical details and early outcomes.

    abstract:Background:Trans-subxiphoid thoracoscopic thymectomy is a promising procedure but technically demanding associated with ergonomic discomfort. In order to facilitate this complex procedure, the authors present a modified trans-subxiphoid thymectomy by the use of the Da Vinci robotic system. Methods:A 2-cm longitudinal ...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章

    doi:10.21037/jtd.2018.03.07

    authors: Zhang H,Chen L,Zheng Y,Wang Z,Geng Y,Wang F,Liu D,He A,Li J,Wang Y

    更新日期:2018-03-01 00:00:00

  • Can lobe-specific lymph node dissection be an alternative to systematic lymph node dissection in treating early-stage non-small cell lung cancer: a comprehensive systematic review and meta-analysis?

    abstract:Background:Whether lobe-specific lymph node dissection (L-SLND) could serve as an alternative to systematic lymph node dissection (SLND) in treating early-stage non-small cell lung cancer (NSCLC) remains unclear. Therefore, we conducted this comprehensive meta-analysis to compare the effect of L-SLND with that of SLND ...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章

    doi:10.21037/jtd.2018.04.137

    authors: Deng HY,Qin CL,Li G,Alai G,Lin Y,Qiu XM,Zhou Q

    更新日期:2018-05-01 00:00:00

  • Heart V5 predicts cardiac events in unresectable lung cancer patients undergoing chemoradiation.

    abstract:Background:Recent studies incorporating dose escalated radiation identified heart dose as a predictor of cardiac toxicity in unresectable lung cancer patients. Whether conventionally dosed radiation impacts cardiac events remains unclear. Methods:Stage III lung cancer patients undergoing definitive chemoradiation to 6...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章

    doi:10.21037/jtd.2019.06.29

    authors: Ni L,Koshy M,Connell P,Pitroda S,Golden DW,Al-Hallaq H,Hubert G,Kauffman G,McCall A,Malik R

    更新日期:2019-06-01 00:00:00

  • Relationship of pleural fluid pH and glucose: a multi-centre study of 2,971 cases.

    abstract:Background:Pleural fluid pH and glucose levels are both recommended in the workup of pleural effusions. Whether their levels correlate and predict each other or contribute independent knowledge is unclear. We aimed to investigate the pH/glucose relationship, assess their concordance and ascertain whether performing bot...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章

    doi:10.21037/jtd.2018.12.101

    authors: Fitzgerald DB,Leong SL,Budgeon CA,Murray K,Rosenstengal A,Smith NA,Bielsa S,Clive AO,Maskell NA,Porcel JM,Lee YCG

    更新日期:2019-01-01 00:00:00

  • Clinical significance of chronic myocardial ischemia in coronary artery disease patients.

    abstract::Myocardial ischemia is considered the cornerstone of the treatment of patients with coronary artery disease (CAD). Although the deleterious effects of myocardial infarction, the maximum expression of ischemia, have been extensively studied and described, the clinical effects of chronic, documented myocardial ischemia ...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章,评审

    doi:10.21037/jtd.2019.02.85

    authors: Rezende PC,Ribas FF,Serrano CV Jr,Hueb W

    更新日期:2019-03-01 00:00:00

  • Accumulation of periostin in acute exacerbation of familial idiopathic pulmonary fibrosis.

    abstract::Periostin, an extracellular matrix molecule, is associated with idiopathic pulmonary fibrosis (IPF). It is known that the frequency of familial IPF (FIPF) ranges from 0.5% to 2.2% among IPF cases. However, the relationship between periostin and FIPF has not been previously described. We report the first case of perios...

    journal_title:Journal of thoracic disease

    pub_type:

    doi:10.21037/jtd.2018.06.96

    authors: Murata K,Koga Y,Kasahara N,Hachisu Y,Nunomura S,Nakajima N,Yokoo H,Kaira K,Maeno T,Dobashi K,Izuhara K,Hisada T

    更新日期:2018-07-01 00:00:00

  • Bronchiectasis after bronchial thermoplasty.

    abstract::Bronchial thermoplasty (BT) is used in the treatment of severe refractory asthma. It has been found to be beneficial to long-term improvements in the rate of asthma exacerbation, quality of life questionnaire answers (AQLQ), hospitalization, and emergency room visits. Atelectasis and lung abscess as direct complicatio...

    journal_title:Journal of thoracic disease

    pub_type:

    doi:10.21037/jtd.2018.09.116

    authors: Qiu M,Lai Z,Wei S,Jiang Q,Xie J,Qiu R,Wang Z,Zhong C,Chen Y,Zhang Q,Li S,Zhong N

    更新日期:2018-10-01 00:00:00

  • The role of red blood cell distribution width in mortality and cardiovascular risk among patients with coronary artery diseases: a systematic review and meta-analysis.

    abstract:BACKGROUND:Red cell distribution width (RDW) might be a novel biomarker that reflects multiple physiological impairments related to atherosclerosis and coronary artery diseases (CAD). We conducted this systematic review and meta-analysis to evaluate the association of RDW between all-cause mortality and fatal/non-fatal...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章

    doi:10.3978/j.issn.2072-1439.2014.09.10

    authors: Su C,Liao LZ,Song Y,Xu ZW,Mei WY

    更新日期:2014-10-01 00:00:00

  • Applications of cell-free circulating tumor DNA detection in EGFR mutant lung cancer.

    abstract::Analyses of cell-free tumor DNA (ctDNA) have provided a non-invasive strategy for cancer diagnosis, the identification of molecular aberrations for treatment identification, and evaluation of tumor response. Sensitive and specific ctDNA sequencing strategies have allowed for implementation into clinical practice for t...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章,评审

    doi:10.21037/jtd.2020.01.66

    authors: Bulbul A,Leal A,Husain H

    更新日期:2020-05-01 00:00:00

  • Outcome of shorter treatment duration in non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease.

    abstract:Background:The recommended treatment duration for non-cavitary nodular bronchiectatic (NC-NB) Mycobacterium avium complex (MAC) lung disease (LD) is at least 12 months after culture conversion, but evidence supporting this is limited. This study investigated whether treatment for less than 12 months after culture conve...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章

    doi:10.21037/jtd.2020.01.39

    authors: Park YE,Chong YP,Kim YJ,Kim OH,Kwon BS,Shim TS,Jo KW

    更新日期:2020-03-01 00:00:00

  • Lung B-line artefacts and their use.

    abstract:BACKGROUND:The analysis of lung artefacts has gained increasing importance as markers of lung pathology. B-line artefact (BLA), caused by a reverberation phenomenon, is the most important lung artefact. In this review, we discuss the current role of BLA in pneumology and explore open questions of the published consensu...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章,评审

    doi:10.21037/jtd.2016.04.55

    authors: Dietrich CF,Mathis G,Blaivas M,Volpicelli G,Seibel A,Wastl D,Atkinson NS,Cui XW,Fan M,Yi D

    更新日期:2016-06-01 00:00:00

  • Options for temporary mechanical circulatory support.

    abstract::Temporary mechanical circulatory support (MCS) refers to a group of devices generally used for less than 30 days to maintain adequate organ perfusion by compensating for a failure of the pumping mechanism of the heart. The increased availability and rapid adoption of new temporary MCS strategies necessitate physicians...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章,评审

    doi:10.3978/j.issn.2072-1439.2015.09.14

    authors: Saffarzadeh A,Bonde P

    更新日期:2015-12-01 00:00:00

  • Robotically assisted minimally invasive mitral valve surgery.

    abstract::Increased recognition of advantages, over the last decade, of minimizing surgical trauma by operating through smaller incisions and its direct impact on reduced postoperative pain, quicker recovery, improved cosmesis and earlier return to work has spurred the minimally invasive cardiac surgical revolution. This transi...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章,评审

    doi:10.3978/j.issn.2072-1439.2013.11.01

    authors: Mandal K,Alwair H,Nifong WL,Chitwood WR Jr

    更新日期:2013-11-01 00:00:00

  • Simultaneous resection of left atrial myxoma and esophageal carcinoma via right thoraco-abdominal approach.

    abstract::Concomitant occurrence of atrial myxoma and esophageal carcinoma is an extremely rare entity. Here we present two cases of synchronously suffered left atrial myxoma and esophageal carcinoma. Both patients underwent simultaneous resection of two tumors via the right thoraco-abdominal approach and recovered well. ...

    journal_title:Journal of thoracic disease

    pub_type:

    doi:10.21037/jtd.2016.05.89

    authors: Ni B,Lu X,Gong Q,Shao Y

    更新日期:2016-07-01 00:00:00

  • Neoadjuvant and consolidation immuno-oncology therapy in stage III non-small cell lung cancer.

    abstract::Lung cancer continues to be the leading cause of cancer death worldwide. Recently, immunotherapy for non-small cell lung cancer (NSCLC) has emerged as a powerful treatment option for advanced lung cancer. The relative success of programmed death 1 (PD-1) and/or programmed death ligand 1 (PD-L1) antibodies in metastati...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章,评审

    doi:10.21037/jtd.2018.01.109

    authors: Yeh J,Marrone KA,Forde PM

    更新日期:2018-02-01 00:00:00

  • Postoperative changes of the free pericardial fat pad for bronchial stump coverage.

    abstract:Background:Bronchopleural fistula (BPF) remains a serious complication after surgery for lung cancer with bronchial resection. A free pericardial fat pad (FPFP) is applied in high-risk cases to reduce BPF frequency. BPF may occur 6 months after surgery. Thus, we evaluated the residual FPFP volume at 6 months after surg...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章

    doi:10.21037/jtd.2019.11.81

    authors: Nagashima T,Ito H,Samejima J,Nemoto D,Eriguchi D,Nakayama H,Woo T,Masuda M

    更新日期:2019-12-01 00:00:00

  • Clinical features of pulmonary mucormycosis in patients with different immune status.

    abstract:Background:Pulmonary mucormycosis (PM) is a relatively rare but often fatal and rapidly progressive disease. Most studies of PM are case reports or case series with limited numbers of patients, and focus on immunocompromised patients. We investigated the clinical manifestations, imaging features, treatment, and outcome...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章

    doi:10.21037/jtd.2019.12.53

    authors: Peng M,Meng H,Sun Y,Xiao Y,Zhang H,Lv K,Cai B

    更新日期:2019-12-01 00:00:00

  • Association between NADPH oxidase (NOX) and lung cancer: a systematic review and meta-analysis.

    abstract:BACKGROUND:Lung cancer is a leading cause of death worldwide. Considerable studies have reported that NADPH oxidase (NOX) expression or activity may play an important role in the tumorigenesis of lung cancer. However, the results are inconsistent. Thus, a systematic review and meta-analysis were conducted in this study...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章

    doi:10.21037/jtd.2016.06.31

    authors: Han M,Zhang T,Yang L,Wang Z,Ruan J,Chang X

    更新日期:2016-07-01 00:00:00

  • PET/CT evaluation of response to chemotherapy in non-small cell lung cancer: PET response criteria in solid tumors (PERCIST) versus response evaluation criteria in solid tumors (RECIST).

    abstract:BACKGROUND:(18)F-FDG PET/CT is increasingly used in evaluation of treatment response for patients with non-small cell lung cancer (NSCLC). There is a need for an accurate criterion to evaluate the effect and predict the prognosis. The aim of this study is to evaluate therapeutic response in NSCLC with comparing PET res...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章

    doi:10.3978/j.issn.2072-1439.2014.05.10

    authors: Ding Q,Cheng X,Yang L,Zhang Q,Chen J,Li T,Shi H

    更新日期:2014-06-01 00:00:00

  • Extracorporeal support, during and after lung transplantation: the history of an idea.

    abstract::During recent years, continuous technological innovation has provoked an increase of extracorporeal life support (ECLS) use for perioperative cardiopulmonary support in lung transplantation. Initial results were disappointing, due to ECLS-specific complications and high surgical risk of the supported patients. However...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章,评审

    doi:10.21037/jtd.2018.07.43

    authors: Ius F,Tudorache I,Warnecke G

    更新日期:2018-08-01 00:00:00

  • Genetic and pharmacological inhibition of eIF4E effectively targets esophageal cancer cells and augments 5-FU's efficacy.

    abstract:Background:Aberrant activation of eIF4E is critically involved in the progression and chemoresistance of various cancers. Elevated expression of eIF4E has also been documented in human cancerous esophageal tissues. However, the role of eIF4E in esophageal cancer is unclear. Methods:We analysed the levels of eIF4E expr...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章

    doi:10.21037/jtd.2018.06.43

    authors: Kai J,Wang Y,Xiong F,Wang S

    更新日期:2018-07-01 00:00:00

  • COPD in India: Iceberg or volcano?

    abstract::The purpose of this article is to provide an overview of the epidemiology of COPD in India which is one of the most affected countries in the world and contributes significantly to the mortality and morbidity of this disease; to provide insights into the etiological determinants of COPD in India; comment on treatment ...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章

    doi:10.3978/j.issn.2072-1439.2012.03.15

    authors: Bhome AB

    更新日期:2012-06-01 00:00:00

  • The role of surgery in high grade neuroendocrine tumours of the lung.

    abstract::High grade lung neuroendocrine tumours are a heterogeneous subtype of pulmonary cancers including small cell lung cancer (SCLC) and large-cell neuroendocrine carcinoma (LCNEC). LCNEC represents approximately 2-3% of lung cancers, whereas SCLC represents 15-20% of lung cancers. Patients with SCLC and LCNEC have a poor ...

    journal_title:Journal of thoracic disease

    pub_type: 杂志文章

    doi:10.21037/jtd.2017.01.60

    authors: Welter S,Aigner C,Roesel C

    更新日期:2017-11-01 00:00:00